Anish Patel is COO at Enliven Therapeutics, Inc. (ELVN). They have made 1 open-market trade across 1 company since 2023, most recently 2026-02-12.
CIK 0001967163
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ELVN | 20,000 | $747K |
Shares reported on the most recent Form 4, priced at the 2026-02-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELVN | SELL · 10b5-1 | 2026-01-09 | 2026-01-13 | $27.98 | $1.4M | +0.7% | +5.8% | +70.7% |
| ELVN | SELL · 10b5-1 | 2025-12-08 | 2025-12-10 | $20.91 | $243K | -10.3% | +30.1% | +51.3% |
| ELVN | SELL · 10b5-1 | 2025-11-07 | 2025-11-12 | $17.38 | $221K | +7.2% | -17.0% | +37.5% |
| ELVN | SELL · 10b5-1 | 2025-10-07 | 2025-10-09 | $20.10 | $268K | -0.4% | -12.0% | -27.3% |
| ELVN | SELL · 10b5-1 | 2025-09-08 | 2025-09-10 | $20.24 | $270K | +4.7% | +9.5% | +2.5% |
| ELVN | SELL · 10b5-1 | 2025-08-07 | 2025-08-11 | $18.22 | $236K | +9.2% | +5.8% | +3.0% |
| ELVN | SELL · 10b5-1 | 2025-07-07 | 2025-07-09 | $19.77 | $258K | +2.5% | -17.1% | -5.7% |
| ELVN | SELL · 10b5-1 | 2025-06-09 | 2025-06-11 | $20.33 | $270K | +10.0% | +16.7% | +2.5% |
| ELVN | SELL · 10b5-1 | 2025-05-07 | 2025-05-09 | $18.35 | $236K | -11.1% | +6.8% | -6.0% |
| ELVN | SELL · 10b5-1 | 2025-04-07 | 2025-04-09 | $18.03 | $238K | +15.7% | +18.6% | +28.3% |
| ELVN | SELL · 10b5-1 | 2025-03-07 | 2025-03-11 | $21.44 | $286K | +1.7% | -28.0% | -1.8% |
| ELVN | SELL | 2025-02-07 | 2025-02-10 | $21.93 | $292K | +2.8% | -0.8% | -10.3% |
| ELVN | SELL · 10b5-1 | 2025-01-07 | 2025-01-10 | $24.18 | $845K | +3.3% | +1.0% | -30.1% |
| ELVN | SELL · 10b5-1 | 2024-10-18 | 2024-10-22 | $30.00 | $21K | -3.8% | -11.6% | -23.4% |
| ELVN | SELL · 10b5-1 | 2024-07-12 | 2024-07-16 | $25.06 | $2.5M | +13.7% | -1.0% | +15.5% |
| ELVN | SELL · 10b5-1 | 2024-06-06 | 2024-06-10 | $20.06 | $23K | -5.0% | +2.1% | +1.9% |
| ELVN | SELL · 10b5-1 | 2024-05-14 | 2024-05-16 | $25.00 | $28K | -11.1% | -10.2% | -9.2% |
| ELVN | SELL · 10b5-1 | 2024-05-09 | 2024-05-13 | $25.06 | $7K | -7.5% | -8.4% | -14.1% |
| ELVN | SELL · 10b5-1 | 2024-05-06 | 2024-05-08 | $22.72 | $111K | -3.4% | -15.7% | -11.8% |
| ELVN | SELL · 10b5-1 | 2024-04-11 | 2024-04-15 | $25.03 | $438K | -14.3% | +22.6% | +28.2% |
| ELVN | SELL · 10b5-1 | 2024-04-08 | 2024-04-10 | $18.55 | $171K | -26.6% | -2.4% | -4.2% |
| ELVN | SELL · 10b5-1 | 2024-03-06 | 2024-03-08 | $15.64 | $76K | +30.8% | +24.6% | +37.5% |
| ELVN | SELL · 10b5-1 | 2024-02-06 | 2024-02-08 | $15.11 | $147K | +3.9% | -13.3% | +57.5% |
| ELVN | SELL · 10b5-1 | 2024-01-22 | 2024-01-24 | $15.14 | $148K | -5.1% | +6.4% | +11.8% |
| ELVN | SELL · 10b5-1 | 2023-12-28 | 2024-01-02 | $15.01 | $203K | -17.9% | +9.8% | +26.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.